| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 71832-69-4 | 2-[2-(2,3-二氢基-1,3-二氧基-1H-茚-2-基)-6-喹啉基]-6-甲基-7-苯并噻唑磺酸与2,2',2"-次氨基三乙醇的 | 7-Benzothiazolesulfonic acid, 2-[2-(2,3-dihydro-1,3-dioxo-1H-inden-2-yl)-6-quinolinyl]-6-methyl-, co; -nitrilotris[ethanol] (1:1) (9CI); olinyl]-6-methyl-, compd. with 2,2',2''-nitrilotris[ethanol] (1:1) | 无 | C26H16N2O5S2.C6H15NO3 | 详情 | 供应商 |
| 1217-08-9 | 2,3-二氢化-β2,3-二氢化-β-1,1,2,3,3-六甲基-1H-茚-5-乙醇 | 1H-Indene-5-ethanol,2,3-dihydro-b,1,1,2,3,3-hexamethyl-; 5-Indanethanol,b,1,1,2,3,3-hexamethyl- (7CI,8CI); 2-(1,1,2,3,3-Pentamethylindan-5-yl)-1-propanol; 2-(1',1',2',3',3'-Pentamethylindan-5'-yl)propanol | ![]() | C17H26O | 详情 | 供应商 |
| 72795-19-8 | (±)-1-[2,3-(二氢-7-甲基1H-茚-4-基)氧]-3-[(1-甲基乙基)氨基]-2-丁醇盐酸盐 | 2-Butanol,1-[(2,3-dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-,(2R,3S)-rel-; 2-Butanol,1-[(2,3-dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-,(R*,S*)-(?à)-; 2-Butanol,1-[(2,3-dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-, (R*,S*)- | ![]() | C17H27NO2 | 详情 | 供应商 |
| 121264-04-8 | (±)-1-[2,3-(二氢-7-甲基氢茚-4-基)氧]-3-[(1-甲基乙基)氨基]-2-丁醇盐酸盐 | ICI 204,448 HYDROCHLORIDE; ici204448; (RS)-[3-[1-[[(3,4-DICHLOROPHENYL)ACETYL]METHYLAMINO]-2-(1-PYRROLIDINYL)ETHYL]PHENOXY]ACETIC ACID HYDROCHLORIDE; ICI 204,448 HYDROCHLORIDE; ICI 204,448 HCL K-OPIOID AGONIST THAT; (R,S)-(3-(1-(((3,4-Dichlorophenyl)acetyl)methylamino)-2-(1-pyrrolidinyl)ethyl)phenoxy)aceticacidhydrochloride; R,S-[3-[1-[[(3,4-Dichlorophenyl)acetyl]methylamino]-2-(1-pyrrolidinyl)ethyl] phenoxy]-acetic acid hydrochloride, (±)-1-[2,3-(Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride | ![]() | C23H27Cl3N2O4 | 详情 | 供应商 |
| 944328-88-5 | QS11; (BETAS)-BETA-[[9-([1,1'-联苯]-4-甲基)-2-[(2,3-二氢-1H-茚-5-基)氧基]-9H-嘌呤-6-基]氨基]苯丙醇 | QS11; QS11; (2S)-2-[2-(Indan-5-yloxy)-9-(1,1'-biphenyl-4-yl)methyl)-9H-purin-6-ylamino]-3-phenyl-propan-1-ol; (betaS)-beta-[[9-([1,1'-Biphenyl]-4-ylmethyl)-2-[(2,3-dihydro-1H-inden-5-yl)oxy]-9H-purin-6-yl]amino]benzenepropanol | 无 | 详情 | 供应商 |